iShares US Healthcare ETF (IYH)
165.19
-0.99 -0.60%
NYSE Arca
Aug 23, 16:59
Delayed 2m
USD
IYH Key Stats
| Expense Ratio | 0.44% |
| Share Class Assets Under Management | 1.964B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 166.22 |
| Discount or Premium to NAV | -0.03% |
| Turnover Ratio | 6.00 |
View All IYH News
IYH News
-
WireHeadlineTime (ET)
-
MT Newswires08/23 13:34
-
Yahoo08/23 11:53
-
MT Newswires08/23 09:25
-
MT Newswires08/22 13:38
-
MT Newswires08/22 09:24
-
Yahoo08/22 07:37
-
MT Newswires08/21 13:31
-
MT Newswires08/21 09:28
-
MT Newswires08/18 13:26
-
MT Newswires08/18 09:21
IYH Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | -3.26% | -3.58% | 6 |
| 3M | 4.85% | 2.80% | 19 |
| 6M | 6.58% | 5.18% | 32 |
| 1Y | 8.00% | 7.50% | 51 |
| 3Y | 9.03% | 7.29% | 30 |
| 5Y | 16.91% | 16.59% | 54 |
| 10Y | 10.96% | 11.41% | 54 |
IYH Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.24% | 0.24% | 0.00 |
| Stock | 99.76% | 99.76% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
IYH Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
IYH Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 99.88% |
| Industrials | 0.12% |
| Real Estate | 0.00 |
| Technology | 0.00 |
| Utilities | 0.00 |
IYH Stock Market Capitalization
| Giant | 46.89% |
| Large | 38.49% |
| Medium | 11.79% |
| Small | 2.71% |
| Micro | 0.11% |
IYH Stock Style Exposure
| Large Cap Value | 28.53% |
| Large Cap Blend | 24.68% |
| Large Cap Growth | 32.26% |
| Mid Cap Value | 1.53% |
| Mid Cap Blend | 3.57% |
| Mid Cap Growth | 6.70% |
| Small Cap Value | 0.45% |
| Small Cap Blend | 0.50% |
| Small Cap Growth | 1.78% |
View More Holdings
As of Aug. 18, 2017
IYH Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 11.55% | 132.61 | -1.55% |
| PFE | Pfizer Inc | 6.30% | 33.28 | +0.39% |
| UNH | UnitedHealth Group Inc | 5.94% | 194.32 | -0.24% |
| MRK | Merck & Co Inc | 5.44% | 62.15 | -0.43% |
| AMGN | Amgen Inc | 3.98% | 169.01 | -0.62% |
| MDT | Medtronic PLC | 3.69% | 79.80 | -2.40% |
| ABBV | AbbVie Inc | 3.60% | 71.51 | -0.33% |
| CELG | Celgene Corp | 3.22% | 129.18 | -0.85% |
| GILD | Gilead Sciences Inc | 3.05% | 73.75 | +0.56% |
| BMY | Bristol-Myers Squibb Company | 3.00% | 57.88 | +0.36% |
Advertisement
IYH One Page Reports
- One Page Report Download
IYH Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
|---|---|
DJ US Health Care TR USD |
100.0% |
IYH Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 1.21 yrs |
| Diane Hsiung | 9.50 yrs |
| Greg Savage | 9.50 yrs |
| Jennifer Hsui | 4.83 yrs |
IYH Net Fund Flows
| 1M | 49.10M |
| 3M | -3.381M |
| 6M | 90.50M |
| YTD | -86.05M |
| 1Y | -133.59M |
| 3Y | -1.084B |
| 5Y | 260.42M |
| 10Y | -357.45M |
IYH Risk Info
| Beta (5Y) | 0.9287 |
| Max Drawdown (All) | 43.52% |
| Historical Sharpe (10Y) | 0.8206 |
| Historical Sortino (All) | 0.6606 |
| 30-Day Rolling Volatility | 8.74% |
| Daily Value at Risk (VaR) 1% (All) | 3.26% |
| Monthly Value at Risk (VaR) 1% (All) | 13.24% |
IYH Fundamentals
| Dividend Yield TTM (8-23-17) | 1.15% |
| SEC Yield (12-31-15) | 1.04% |
| Weighted Average PE Ratio | 24.42 |
| Weighted Average Price to Sales Ratio | 2.369 |
| Weighted Average Price to Book Ratio | 3.923 |
| Weighted Median ROE | 20.00% |
| Weighted Median ROA | 7.01% |
| Forecasted Dividend Yield | 1.62% |
| Forecasted PE Ratio | 21.45 |
| Forecasted Price to Sales Ratio | 2.200 |
| Forecasted Price to Book Ratio | 3.413 |
| Number of Holdings | 120 |
IYH Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.27% |
| Forecasted Book Value Growth | 8.97% |
| Forecasted Cash Flow Growth | 13.79% |
| Forecasted Earnings Growth | 9.95% |
| Forecasted Revenue Growth | 9.14% |
IYH Comparables
EditIYH Attributes
| Key Dates | |
|---|---|
| Inception Date | 6/12/2000 |
| Last Annual Report Date | 4/30/2017 |
| Last Prospectus Date | 9/1/2016 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
IYH Excel Add-In Codes
- Name: =YCI("IYH","name")
- Broad Asset Class: =YCI("IYH", "broad_asset_class")
- Broad Category: =YCI("IYH", "broad_category_group")
- Prospectus Objective: =YCI("IYH", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
